Correlation Between Bone Biologics and LENSAR

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bone Biologics and LENSAR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bone Biologics and LENSAR into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bone Biologics Corp and LENSAR Inc, you can compare the effects of market volatilities on Bone Biologics and LENSAR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bone Biologics with a short position of LENSAR. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bone Biologics and LENSAR.

Diversification Opportunities for Bone Biologics and LENSAR

-0.8
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Bone and LENSAR is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Bone Biologics Corp and LENSAR Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LENSAR Inc and Bone Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bone Biologics Corp are associated (or correlated) with LENSAR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LENSAR Inc has no effect on the direction of Bone Biologics i.e., Bone Biologics and LENSAR go up and down completely randomly.

Pair Corralation between Bone Biologics and LENSAR

Assuming the 90 days horizon Bone Biologics Corp is expected to generate 4.88 times more return on investment than LENSAR. However, Bone Biologics is 4.88 times more volatile than LENSAR Inc. It trades about 0.05 of its potential returns per unit of risk. LENSAR Inc is currently generating about 0.18 per unit of risk. If you would invest  6,050  in Bone Biologics Corp on September 3, 2024 and sell it today you would lose (3,270) from holding Bone Biologics Corp or give up 54.05% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Bone Biologics Corp  vs.  LENSAR Inc

 Performance 
       Timeline  
Bone Biologics Corp 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Bone Biologics Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating technical and fundamental indicators, Bone Biologics showed solid returns over the last few months and may actually be approaching a breakup point.
LENSAR Inc 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in LENSAR Inc are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain basic indicators, LENSAR reported solid returns over the last few months and may actually be approaching a breakup point.

Bone Biologics and LENSAR Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bone Biologics and LENSAR

The main advantage of trading using opposite Bone Biologics and LENSAR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bone Biologics position performs unexpectedly, LENSAR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LENSAR will offset losses from the drop in LENSAR's long position.
The idea behind Bone Biologics Corp and LENSAR Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Transaction History
View history of all your transactions and understand their impact on performance